Ginkgo Bioworks Holdings, Inc. Class A DNA 深 沪
已收盘 05-15 16:00:00 美东时间
7.71
-0.140
-1.78%
华盛通- 最 高7.82
- 今 开7.58
- 成交量 104.57万股
- 最 低 7.53
- 昨 收 7.85
- 总市值 4.79亿
- 52周最高 17.58
- 市盈率 静 --
- 换手率 1.68%
- 52周最低 5.37
- 委 比 -63.64%
- 总股本 6213.54万
- 历史最高 634.56
- 量 比 0.70
- 振 幅 3.69%
- 历史最低 5.00
- 每 手 1
- 风险率 2.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ Ginkgo Bioworks(DNA)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Ginkgo Bioworks 2026年第一季度业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度营收为1900万美元，同比下降49%。剔除2025年第一季度BiomEdit协议终止产生的750万美元非现金收入后，调整后营收同比下降37%。 **亏损情况：** 持续经营业务净亏损7600万美元，较2025年第一季度的8300万美元有所改善，主要得益于重组措施。 **调整后EBITDA：** 负4200万美元，较去年同期负4400万美元略有改善。值得注意的是，该指标现包含1600万美元的闲置租赁空间
05-09 12:12
Ginkgo Bioworks Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results.
Ginkgo Bioworks Holdings shares are trading lower after the company reported wo...
05-08 05:23
ProQR Therapeutics Collaborates With Ginkgo Bioworks Over Access To 50+ Instrument Autonomous Lab Nebula
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced its AI
04-08 20:02
美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $9 to $5.
03-12 19:12
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
Elon Musk tweeted about wanting Jurassic Park in real life. Companies aren't bringing back dinosaurs yet, but they are bringing extinct items back to life.
03-08 04:01
Ginkgo Bioworks Rolls Out Ginkgo Cloud Lab
Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to Ginkgo's autonomous lab infrastructure directly through a web
03-02 21:08
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
BOSTON, March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork...
03-02 21:00
Ginkgo Bioworks To Spin Off Biosecurity Business To Investor Consortium In Exchange For A Minority Equity Position In The Business Alongside The Investors
Ginkgo today announced it has reached an agreement to sell the Company's biosecurity business to a consortium of investors ("Investors") in exchange for a minority equity position in the business alongside the Investors.
02-27 05:47
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses of $(2.00) per share
02-27 05:33
